We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bayer Biological Products (Bayer BP) is employing innovative antitampering strategies as part of a companywide effort to combat product tampering and counterfeiting.
Pacemakers and newer implantable cardioverter defibrillators (ICDs) do not pose the same electromagnetic interference problems to magnetic resonance imaging (MRI) scans that many predecessor devices do, according to a recent study.
A drug industry task force has recommended that the use of radio-frequency tags to identify and track drug products at the individual item level be at the heart of a system to secure product integrity throughout the supply chain.
A pharmaceutical industry task force has recommended that the use of radio-frequency tags for identifying and tracking drug products at the individual item level be at the heart of a system to secure product integrity throughout the supply chain.
Guidant confirmed July 1 that its drug-eluting Champion stent will face a six- to eight-month delay to correct a stent platform flaw, but will require no additional clinical data to satisfy FDA regulators.
As radio-frequency identification (RFID) technology matures and becomes integral to the supply chain, many manufacturing executives are beginning to expect high returns from their investments in RFID systems.
While track-and-trace technologies such as bar coding are set to play a critical role not only in securing the pharmaceutical supply chain but also in preventing drug-dispensing mistakes, the FDA has failed to mandate that one critical element of the healthcare sector — hospitals — adopt the necessary technology.
Heart stents that feature a thinner design with fewer linkages may reduce the rate of scar tissue that builds in vessels following stent placement, according to a new study published in the July issue of the Journal of Applied Physiology.